Did you know there’s even more we can do to promote your episode? Find out more…
Episode 221
The COO leveraging the ‘power of we’
Christiane Bardroff
/ Rentschler Biopharma SE
Hear from Christiane Bardroff, COO of Rentschler Biopharma, as she shares insights on biologics, leadership, and scaling global operations.
Episode 220
The pharma CEO focused on US commercial growth
Adriana Herrera
/ Pierre Fabre Pharmaceuticals (USA).
Explore Adriana Herrera’s journey from Kite Pharma to CEO at Pierre Fabre USA, leading in cell therapy, oncology, and pharma innovation.
Episode 219
The Spanish solid state specialist
Victor Diaz
/ Solitek
Discover Victor Diaz’s journey from medicinal chemist to co-founder of Solitek, and his insights on solid-state chemistry, AI in drug development, and the future of CROs/CDMOs.
Episode 218
The bullish CDMO CEO making bold moves
Jeremie Trouchu
/ Ardena
Hear Jeremie Trochu’s journey from GE to Catalent and now Ardena, as he shares insights on CDMO growth and navigating the pharma landscape.
Episode 217
Geordie lad done good in pharma
Rob Wood
/
Discover Rob Wood’s journey from founding STEM to leading pharma investments and launching an academy for future entrepreneurs.
Episode 216
The CEO driven by lentiviral vector success
Jon Alberdi
/ VIVEbiotech
Jon Alberdi, CEO at VIVEbiotech, shares his journey from automotive to biotech, with insights on viral vectors, PE impact, and CGT growth.
Episode 215
The CRDMO CEO making his luck
Philip Lee
/ Genefab
Philip Lee shares his journey from startup founder to GeneFab CEO, building and scaling breakthrough life sciences ventures.
Episode 214
The biotech CEO focused on curing paediatric deafness
Jodi Cook, PhD
/ Skylark Bio
Get inspired by Jodi Cook, CEO of Skylark Bio, as she shares her biotech journey, gene therapy insights, and leadership lessons.
Episode 213
Inside the mind of the CDMO customer
Julien Laizé
/ Valneva
Julien Laizé joins us to explore CDMO selection, in-house vs outsourced manufacturing, and the evolving challenges in external manufacturing.
Episode 212
The master-builder now on a cell therapy crusade
Jason C. Foster
/ Ori Biotech
Jason C. Foster shares his journey from big pharma to leading Ori Biotech and tackling cell and gene therapy manufacturing.
